Pharmaceutical Engineering® magazine is proud to announce the 2021 Roger F. Sherwood Article of the Year is “Medical Device UDI Components Management in the European Union”

Pharmaceutical Engineering® magazine is proud to announce the 2021 Roger F. Sherwood Article of the Year is “Medical Device UDI Components Management in the European Union”
Millstone Medical Outsourcing announces the groundbreaking for a third cleanroom facility expansion at its Fall River, MA headquarters.
The Pennsylvania Biotechnology Center partnership offers biotech residents flexible, plug & play lab and research space within a...
Olympus announced today the results of a pilot study showing the safety and effectiveness of the ViziShot 2 FLEX 19 G EBUS-TBNA Needle in gathering tissue samples critical to guiding treatment of non-small cell lung cancer (NSCLC).
Boston Scientific completes the acquisition of the global surgical business of Lumenis LTD., a privately-held company that develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA).
Spectrum Plastics Group, a global solutions provider for development through scaled manufacturing of critical polymer-based components and devices for medical and other demanding markets, is excited to announce a significant renovation and cleanroom expansion project at its Minneapolis, MN facility.
Proposed acquisition of Trillium strengthens Pfizer’s category leadership in Oncology with addition of next-generation, investigational immuno-therapeutics for hematological malignancies
Signature Biologics, LLC., today announced their expanded operations footprint to include a new 36,000 sq ft facility in Irving, TX. This newly constructed space mirrors Signature Biologics’ transparency in doing business with open floor plan and floor-to-ceiling views into its fully equipped manufacturing and R&D laboratory spaces.
Cytiva, a global life sciences leader, has partnered with Mycenax Biotech Inc, a leading biopharmaceutical CDMO company, to launch Taiwan’s first continuous bioprocessing lab.
Artiva Biotherapeutics, an oncology company specializing in primary allogeneic natural killer (NK) cell therapies to treat cancer, announced on Aug. 12, 2021 an expansion of its US presence with a new R&D and GMP manufacturing facility in San Diego, Calif., for cell therapies.
New facility at the existing facility in Milford, MA, USA will significantly expand cGMP manufacturing capabilities and accelerate the clinical and commercial supply of vital biopharmaceuticals
Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services, is opening the Ecolab Healthcare Advanced Design Center in Eagan, Minn.